Aspen Aerogels (NYSE:ASPN) Price Target Cut to $3.00 by Analysts at Barclays

Aspen Aerogels (NYSE:ASPN) had its price objective trimmed by Barclays from $4.00 to $3.00 in a research report report published on Thursday morning,Benzinga reports. The firm currently has an underweight rating on the construction company’s stock.

ASPN has been the topic of several other reports. Roth Mkm cut their price objective on shares of Aspen Aerogels from $6.00 to $3.00 and set a “buy” rating on the stock in a report on Thursday, February 26th. TD Cowen cut their price target on Aspen Aerogels from $7.00 to $6.00 and set a “buy” rating on the stock in a report on Thursday, February 26th. Weiss Ratings reissued a “sell (d-)” rating on shares of Aspen Aerogels in a research report on Monday, December 29th. Zacks Research raised Aspen Aerogels from a “strong sell” rating to a “hold” rating in a research report on Thursday, January 15th. Finally, Canaccord Genuity Group reduced their target price on shares of Aspen Aerogels from $10.00 to $5.00 and set a “buy” rating for the company in a report on Friday, November 7th. Three investment analysts have rated the stock with a Buy rating, two have issued a Hold rating and two have given a Sell rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $4.25.

Aspen Aerogels Stock Performance

Shares of Aspen Aerogels stock opened at $3.30 on Thursday. The company has a current ratio of 3.94, a quick ratio of 3.33 and a debt-to-equity ratio of 0.28. The stock’s fifty day moving average price is $3.35 and its 200-day moving average price is $4.93. The firm has a market cap of $272.75 million, a P/E ratio of -0.70 and a beta of 2.99. Aspen Aerogels has a 12 month low of $2.30 and a 12 month high of $9.78.

Aspen Aerogels (NYSE:ASPN) last issued its earnings results on Wednesday, February 25th. The construction company reported ($0.34) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.27) by ($0.07). The business had revenue of $41.34 million for the quarter, compared to the consensus estimate of $44.25 million. Aspen Aerogels had a negative return on equity of 13.07% and a negative net margin of 143.69%.The firm’s revenue was down 66.4% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.14 earnings per share. Aspen Aerogels has set its Q1 2026 guidance at -0.280–0.240 EPS. On average, equities research analysts expect that Aspen Aerogels will post 0.17 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Aspen Aerogels

Several institutional investors have recently added to or reduced their stakes in ASPN. Raymond James Financial Inc. increased its holdings in shares of Aspen Aerogels by 6.8% during the second quarter. Raymond James Financial Inc. now owns 26,559 shares of the construction company’s stock valued at $157,000 after acquiring an additional 1,687 shares in the last quarter. Legal & General Group Plc grew its position in Aspen Aerogels by 3.6% during the 2nd quarter. Legal & General Group Plc now owns 67,130 shares of the construction company’s stock worth $397,000 after purchasing an additional 2,324 shares during the last quarter. Osaic Holdings Inc. increased its stake in Aspen Aerogels by 29.1% during the 2nd quarter. Osaic Holdings Inc. now owns 10,615 shares of the construction company’s stock valued at $63,000 after purchasing an additional 2,390 shares in the last quarter. SBI Securities Co. Ltd. raised its holdings in shares of Aspen Aerogels by 67.3% in the second quarter. SBI Securities Co. Ltd. now owns 6,343 shares of the construction company’s stock worth $38,000 after buying an additional 2,551 shares during the last quarter. Finally, The Manufacturers Life Insurance Company lifted its stake in shares of Aspen Aerogels by 12.1% during the second quarter. The Manufacturers Life Insurance Company now owns 24,671 shares of the construction company’s stock worth $146,000 after buying an additional 2,656 shares during the period. Institutional investors and hedge funds own 97.64% of the company’s stock.

About Aspen Aerogels

Aspen Aerogels, Inc, headquartered in Northborough, Massachusetts, develops and manufactures high-performance aerogel insulation materials and custom engineered solutions. Founded in 2001 as a spin-out from Department of Energy research, the company pursued an initial public offering on the NYSE in 2014 under the ticker ASPN. Aspen Aerogels combines proprietary aerogel formulations with advanced manufacturing processes to deliver products known for their low thermal conductivity, lightweight construction and robust mechanical properties.

The company’s product portfolio spans blanket insulation, boards, and custom shapes built around several proprietary brands, including Pyrogel, Cryogel and Spaceloft.